Type I Interferon Receptor Antagonist [EPC]

54 reported adverse events

Drugs of this class: ANIFROLUMAB

These side effects are most commonly reported by patients taking drugs of the Type I Interferon Receptor Antagonist [EPC] class:

# Side effect Count
0 FATIGUE 4
1 BONE PAIN 2
2 CHEST PAIN 2
3 DEATH 2
4 HEART RATE INCREASED 2
5 INSOMNIA 2
6 NAUSEA 2
7 THROAT TIGHTNESS 2
8 ABDOMINAL DISCOMFORT 1
9 ABDOMINAL DISTENSION 1
See all common reactions for Type I Interferon Receptor Antagonist [EPC]

Drugs of the Type I Interferon Receptor Antagonist [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SQUAMOUS CELL CARCINOMA OF THE CERVIX 1 0.0066
1 INVASIVE BREAST CARCINOMA 1 0.0044
2 INFUSION SITE URTICARIA 1 0.0027
3 VASCULAR RUPTURE 1 0.0008
4 INFUSION SITE PRURITUS 1 0.0006
5 B-CELL LYMPHOMA 1 0.0004
6 EPIGASTRIC DISCOMFORT 1 0.0003
7 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
8 ENCEPHALITIS 1 0.0002
9 UPPER-AIRWAY COUGH SYNDROME 1 0.0002
See all enriched reactions for Type I Interferon Receptor Antagonist [EPC]